Concepedia

<scp>SOST</scp>, an <scp>LNGFR</scp> target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells

Gang Li, Junyu Liu, Manzhu Zhao, Yingying Wang, Kun Yang, Chang Liu, Yong Xiao, Xiujie Wen, Luchuan Liu

Cell Proliferation · 2017 · 14 citations · 36 references

DOIFull text

Open access

Abstract

SOST alleviated the osteogenic differentiation of EMSCs, and LNGFR enhanced the osteogenic differentiation of EMSCs by decreasing SOST, suggesting that the LNGFR/SOST pathway may be a novel target for promoting dental tissue regeneration and engineering.

References

36

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

D. G. Winkler · The EMBO Journal · 2003 · 1.1K citations · Full text

, , +14

Glial origin of mesenchymal stem cells in a tooth model system

Nina Kaukua, Maryam Khatibi Shahidi, Chrysoula Konstantinidou et al. · Nature · 2014 · 411 citations

, , +14

Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

Emma C. Walker, Narelle E. McGregor, Ingrid J. Poulton et al. · Journal of Clinical Investigation · 2010 · 293 citations · Full text

, , +16

Parathyroid hormone (PTH)–induced bone gain is blunted in <i>SOST</i> overexpressing and deficient mice

Ina Krämer, Gabriela G. Loots, Anne Studer et al. · Journal of Bone and Mineral Research · 2009 · 242 citations · Full text

, , +15

Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses

William F Powell, Kevin J. Barry, Irena Tulum et al. · Journal of Endocrinology · 2011 · 196 citations · Full text